Blues health insurers fund U.S. non-profit's generic drug expansion

A group of Blue Cross Blue Shield insurers is investing $55 million in a new venture with a non-profit generic drug manufacturer to try to offer cheaper prices on pharmacy drugs to their members, the companies said on Thursday.